Pancreatic cancers, often driven by mutant KRas and, commonly, genetic loss of SMAD4, have an extraordinarily high content of stromal fibroblasts and ECM interspersed with pockets of thriving tumor cells. Here, SMAD4 is linked to neoplasm.